
Brian A. Mccaig
Examiner (ID: 12226, Phone: (571)270-5548 , Office: P/1772 )
| Most Active Art Unit | 1772 |
| Art Unit(s) | 1772, 1774, 1797 |
| Total Applications | 1729 |
| Issued Applications | 1395 |
| Pending Applications | 82 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 17/172403 | OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY | Feb 9, 2021 | Abandoned |
Array
(
[id] => 16853559
[patent_doc_number] => 20210154304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 17/169390
[patent_app_country] => US
[patent_app_date] => 2021-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/169390 | Compositions, formulations and interleukin production and purification | Feb 4, 2021 | Issued |
Array
(
[id] => 19310452
[patent_doc_number] => 12036246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Compositions and methods for enhancing cancer chemotherapy
[patent_app_type] => utility
[patent_app_number] => 17/163793
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 112
[patent_figures_cnt] => 113
[patent_no_of_words] => 15405
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 745
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163793 | Compositions and methods for enhancing cancer chemotherapy | Jan 31, 2021 | Issued |
Array
(
[id] => 16961572
[patent_doc_number] => 20210213071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/161447
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161447 | Compositions and methods for enhancing cancer immunotherapy | Jan 27, 2021 | Issued |
Array
(
[id] => 17255842
[patent_doc_number] => 20210368827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COMPOSITION AND/OR COMBINATION FOR AQUACULTURE
[patent_app_type] => utility
[patent_app_number] => 17/150254
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150254 | Composition and/or combination for aquaculture | Jan 14, 2021 | Issued |
Array
(
[id] => 17952432
[patent_doc_number] => 11478505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Compositions of ixabepilone
[patent_app_type] => utility
[patent_app_number] => 17/144405
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27801
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17144405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/144405 | Compositions of ixabepilone | Jan 7, 2021 | Issued |
Array
(
[id] => 16961458
[patent_doc_number] => 20210212957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => MEDICAL DEVICE FOR PREVENTING AND/OR TREATING INFECTIONS OF SKIN LESIONS
[patent_app_type] => utility
[patent_app_number] => 17/145057
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145057
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/145057 | MEDICAL DEVICE FOR PREVENTING AND/OR TREATING INFECTIONS OF SKIN LESIONS | Jan 7, 2021 | Abandoned |
Array
(
[id] => 20541115
[patent_doc_number] => 20260048003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-19
[patent_title] => STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/810142
[patent_app_country] => US
[patent_app_date] => 2021-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810142 | STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION | Jan 7, 2021 | Pending |
Array
(
[id] => 18171737
[patent_doc_number] => 11571429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Method and compounds for treating peripheral neuropathy
[patent_app_type] => utility
[patent_app_number] => 17/135158
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 14450
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135158 | Method and compounds for treating peripheral neuropathy | Dec 27, 2020 | Issued |
Array
(
[id] => 16837746
[patent_doc_number] => 20210145758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => ENCAPSULATED ANTIMICROBIALS AND RELATED METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/108947
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108947 | Encapsulated antimicrobials and related methods of treatment | Nov 30, 2020 | Issued |
Array
(
[id] => 18093340
[patent_doc_number] => 20220411681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Adhesive Composition
[patent_app_type] => utility
[patent_app_number] => 17/781314
[patent_app_country] => US
[patent_app_date] => 2020-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781314 | Adhesive Composition | Nov 29, 2020 | Abandoned |
Array
(
[id] => 17625604
[patent_doc_number] => 20220160619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Effervescent Drug Formulations
[patent_app_type] => utility
[patent_app_number] => 17/104238
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104238 | Effervescent Drug Formulations | Nov 24, 2020 | Abandoned |
Array
(
[id] => 16946752
[patent_doc_number] => 20210205443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response
[patent_app_type] => utility
[patent_app_number] => 17/247045
[patent_app_country] => US
[patent_app_date] => 2020-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/247045 | Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response | Nov 23, 2020 | Abandoned |
Array
(
[id] => 16791857
[patent_doc_number] => 20210121674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => JAPANESE ENCEPHALITIS VACCINE-CONTAINING MICRONEEDLE ARRAY
[patent_app_type] => utility
[patent_app_number] => 17/100495
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17100495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/100495 | JAPANESE ENCEPHALITIS VACCINE-CONTAINING MICRONEEDLE ARRAY | Nov 19, 2020 | Abandoned |
Array
(
[id] => 16837849
[patent_doc_number] => 20210145861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => CHITOSAN CONTAINING COMPOSITIONS AND METHODS RELATING TO SAME
[patent_app_type] => utility
[patent_app_number] => 16/950359
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6288
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950359 | CHITOSAN CONTAINING COMPOSITIONS AND METHODS RELATING TO SAME | Nov 16, 2020 | Abandoned |
Array
(
[id] => 18197256
[patent_doc_number] => 20230050775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => HAIR COSMETIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/788266
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788266 | HAIR COSMETIC COMPOSITION | Nov 15, 2020 | Pending |
Array
(
[id] => 18656061
[patent_doc_number] => 20230301927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/776723
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776723 | PROCESS FOR PRODUCING AN ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION WITH COLONIC DELIVERY | Nov 12, 2020 | Pending |
Array
(
[id] => 16655982
[patent_doc_number] => 20210052618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => FORMULATION OF GLUCOSINOLATES AND MYROSINASE
[patent_app_type] => utility
[patent_app_number] => 17/093302
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17093302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/093302 | FORMULATION OF GLUCOSINOLATES AND MYROSINASE | Nov 8, 2020 | Abandoned |
Array
(
[id] => 17733339
[patent_doc_number] => 20220218798
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-07-14
[patent_title] => COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
[patent_app_type] => utility
[patent_app_number] => 17/092184
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092184 | COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS | Nov 5, 2020 | Abandoned |
Array
(
[id] => 17020979
[patent_doc_number] => 20210244850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => INJECTABLE SILK FIBROIN PARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/091835
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091835 | INJECTABLE SILK FIBROIN PARTICLES AND USES THEREOF | Nov 5, 2020 | Abandoned |